Background: Hypertension is one of the most common chronic diseases worldwide. It is also one of the most important risk factors related to public health that leads to multiple consequences. On the other hand, hypertension constitutes a heavy burden on health expenditures, especially in developing countries with limited income. Through this study, we aim to identify the reality of hypertension in Syria as a country that has been suffering from war for more than 14 years, through the distribution of doctors practicing and treating hypertension, the availability of various medications to treat it, and the extent to which international guidelines can be applied in clinical practice. Methods: Cardiologists and nephrologists were mainly counted and distributed in Syrian cities. Pharmaceutical companies and drug types produced by these companies were also counted, and drugs were distributed according to therapeutic drug groups. A questionnaire was conducted on the most important types of drugs used by doctors according to different indications. Results: We found that the largest number of cardiologists and nephrologists are located in the capital, Damascus, with a significant preponderance of cardiologists. We also found a significant shortage in the presence of specialists in the eastern governorates and a severe shortage in the number of kidney doctors in the central, northern and eastern governorates, with most of them being in the capital. There was diversity and distribution in most of the drug categories for treating high blood pressure in the first lines of treatment, noting the lack of sufficient intravenous categories. Conclusions: There is a clear shortage in cardiologists and nephrologists in most governorates, with an almost complete absence of intravenous hypertension medications.